drugset
drugset / Trial / NCT00002259

Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma

NCT00002259 ↗

Phase 2 Completed Lederle Laboratories
Treatment

Summary

To study the toxicity and efficacy of IV mitoxantrone hydrochloride (Novantrone) in AIDS-related Kaposi's sarcoma.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Mitoxantrone Small molecule — Intravenous

Indications

HIV infectious disease Kaposi's sarcoma